MedCity News July 18, 2019
Alaric DeArment

Silicon Valley Bank released its healthcare investments and exits trend report for the first half of 2019. It shows, among other things, oncology losing its first-place status in terms of Series A dollars raised.

Venture capital fundraising this year by biopharma startups is on course to fall behind last year, though it will be above the figure for 2017. But the biggest story may be where that funding is going.

Silicon Valley Bank released its 2019 midyear report, “Trends in Healthcare Investments and Exits 2019,” on Thursday. So far, healthcare companies have raised $5.8 billion in the first half of this year, compared with $9.6 billion for all of 2018 and $9.1 billion in 2017.

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Investments, Market Research, Pharma, Precision Medicine, Technology, Trends
Cofactor AI Nabs $4M to Combat Hospital Claim Denials with AI
Infinitus Systems Raises $51.5 Million Series C Funding on the Strength of AI Guardrails
Synapticure Secures $25M To Scale Virtual Care for Neurodegenerative Diseases
Twin Brothers Launch Seen Health with $22M to Provide Culturally-Focused Care for Seniors
Pediatric Therapy Provider Cortica Raises $80M from JPMorgan Entity, Specialty Venture Firms

Share This Article